Publications by authors named "A Assa"

Claim this Profile
D
Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders.
Sohail Aziz, Maria Giovanna Puoti, Amit Assa, Zrinjka Misak, Emmanuel Mas

J Pediatr Gastroenterol Nutr· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration.
Q Zhao, M M E Jongsma, S A Vuijk, B C M de Winter, C Martinez-Vinson, Amit Assa

Clin Pharmacokinet· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration.
Q Zhao, M M E Jongsma, S A Vuijk, B C M de Winter, C Martinez-Vinson, Amit Assa

Clin Pharmacokinet· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A management strategy for nonvariceal gastrointestinal bleeding in children: An ESPGHAN position paper.
Mike Thomson, Jorge Amil-Dias, Amit Assa, Valerio Balassone, Patrick Bontems

J Pediatr Gastroenterol Nutr· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper.
Dan Turner, Amit Assa, Mikkel Malham, Shira Yuval Bar-Asher, Carla Rayan

J Pediatr Gastroenterol Nutr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis